What Is 5-MAPB?

5-MAPB (5-(2-methylaminopropyl)benzofuran) is a synthetic benzofuran compound that has attracted scientific interest because of its structural and pharmacological similarities to certain substituted amphetamines and entactogenic compounds. It belongs to the benzofuran family, a class of compounds investigated for their interactions with monoamine neurotransmitter systems.

Chemical Information

Chemical Name

5-(2-Methylaminopropyl)benzofuran

Molecular Formula

C12H15NO

Molecular Weight

189.25 g/mol

History of 5-MAPB

Benzofuran compounds emerged during research into molecules structurally related to MDMA and other psychoactive phenethylamines. Scientists investigated modifications of aromatic ring systems to better understand how structural changes influence receptor binding and neurotransmitter release.

5-MAPB later appeared in forensic analyses as part of the broader group of novel psychoactive substances (NPS). Since then, toxicologists and pharmacologists have continued studying its chemical properties, metabolism, and pharmacodynamics.

Chemical Structure

5-MAPB contains:

• A benzofuran ring system
• A substituted aminopropyl side chain
• Structural similarities to MDMA
• Distinct differences that influence receptor affinity and metabolism

Replacing the benzene ring found in certain substituted amphetamines with a benzofuran ring alters the compound's interaction with monoamine transporters and receptors.

Serotonin Activity

The serotonin system appears to be the principal target of 5-MAPB.

In vitro studies suggest it promotes serotonin release and inhibits serotonin reuptake, resulting in increased serotonin availability. Because serotonin regulates mood, social behavior, appetite, sleep, and thermoregulation, compounds affecting this system are of particular interest in neuropharmacology.

Receptor Binding

Experimental studies suggest that 5-MAPB may interact with several serotonin receptor subtypes in addition to monoamine transporters. Ongoing research continues to examine receptor affinity profiles and downstream signaling pathways.

Serotonin Syndrome

As a potent serotonergic compound, 5-MAPB may increase the risk of serotonin toxicity, particularly when combined with other serotonergic substances such as certain antidepressants, stimulants, or monoamine oxidase inhibitors (MAOIs). Serotonin syndrome is a potentially life-threatening medical emergency that requires prompt evaluation.

Conclusion

5-MAPB is a synthetic benzofuran compound of scientific interest because of its interactions with serotonin, dopamine, and norepinephrine systems. Current knowledge is based largely on laboratory experiments, analytical chemistry, toxicology, forensic investigations, and limited observational evidence. While research has improved understanding of its pharmacological properties, significant gaps remain regarding human pharmacokinetics, long-term safety, and clinical effects. Continued peer-reviewed research is necessary to clarify its mechanisms, toxicology, metabolism, and potential applications within basic neuroscience and pharmacological research.